Methodology for Developing an Occlusal Appliance With CBD Active Carrier

• Status: Recruiting
• Trial end date: 2023-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation of the efficacy of the occlusal appliance with active cannabidiol (CBD) molecules in TMD patients

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Medical University of Silesia
• Treatments: Salicylic Acid

Criteria

Inclusion Criteria:

• patient agreement to take part in the study

• RDC/TMD group Ia and Ib

• Bruxism Index> 3 ( Brux-off polysomnography)

Exclusion Criteria:

• CBD allergy/hypersensitivity/ addiction

• Therapy with analgesic drugs

• Therapy with drugs affecting muscle function

• Fixed or removable dental prosthesis

• Ongoing orthodontic treatment

• Other general disorders affecting muscle tension